StonvexLoading…
StonvexStonvexStonvexCore line items from MDXG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $418.63M | $348.88M | $321.48M | $267.84M |
Operating Income | $63.89M | $58.87M | $37.12M | $-14.73M |
Net Income | $48.58M | $42.42M | $58.23M | $-30.20M |
EPS (Diluted) | $0.32 | $0.28 | $0.37 | $-0.33 |
Total Assets | $342.65M | $263.92M | $239.05M | $171.43M |
Total Liabilities | $86.11M | $70.81M | $96.33M | $96.92M |
Cash & Equivalents | $166.12M | $104.42M | $82.00M | $65.95M |
Free Cash Flow OCF − CapEx | $72.97M | $64.52M | $24.79M | $-19.41M |
Shares Outstanding | 148.09M | 146.93M | 146.23M | 113.71M |